CardioNXT Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 11

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 5

CardioNXT General Information

Description

Developer of an AI-based precision therapy designed to detect cardiac arrhythmias. The company's platform offers three-dimensional imaging, electromagnetic sensor integration, contact detection, and lesion tagging capabilities, enabling electrophysiologists and cardiac care teams to navigate catheters precisely and perform minimally invasive procedures.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 12011 North Tejon Street
  • Suite 700
  • Westminster, CO 80234
  • United States
+1 (720)
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Other Healthcare Technology Systems
Corporate Office
  • 12011 North Tejon Street
  • Suite 700
  • Westminster, CO 80234
  • United States
+1 (720)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CardioNXT Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private Completed Clinical Trials - General
5. Later Stage VC (Series C) 29-Jul-2019 Completed Clinical Trials - General
4. Later Stage VC (Series B) 01-Jun-2017 Completed Clinical Trials - General
3. Early Stage VC (Series A1) 31-May-2016 Completed Clinical Trials - General
2. Grant 14-May-2015 $250K $1M Completed Startup
1. Early Stage VC (Series A) 22-Aug-2012 $1M $1M Completed Startup
To view CardioNXT’s complete valuation and funding history, request access »

CardioNXT Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series C
Series B
Series A1 2,691,399 $0.001000 6% $0.46 $0.46 1x $0.46 7.84%
Series A 6,697,488 $0.001000 6% $0.15 $0.15 1x $0.15 19.5%
To view CardioNXT’s complete cap table history, request access »

CardioNXT Patents

CardioNXT Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4798068-A1 Apparatus and method for measuring and applying high voltage through a matrix of wires and conductive elements Pending 24-Oct-2023
US-20250387068-A1 Apparatus and method for measuring and applying high voltage through a matrix of wires and conductive elements Pending 24-Oct-2023
WO-2025090690-A1 Apparatus and method for measuring and applying high voltage through a matrix of wires and conductive elements Inactive 24-Oct-2023
US-20190000339-A1 Systems, apparatus, and methods for electro-anatomical mapping of a catheter with electrode contact assessment and rotor projection Inactive 27-Jul-2015
US-20150313491-A1 Methods, systems, and apparatus for identification, characterization, and treatment of rotors associated with fibrillation Active 05-May-2014 A61B5/343
To view CardioNXT’s complete patent history, request access »

CardioNXT Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CardioNXT Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Piedmont Capital Partners Real Estate Minority
Angel (individual) Minority
Solas BioVentures Venture Capital Minority
Colorado Venture Capital Authority Government Minority
To view CardioNXT’s complete investors history, request access »

CardioNXT FAQs

  • When was CardioNXT founded?

    CardioNXT was founded in 2012.

  • Where is CardioNXT headquartered?

    CardioNXT is headquartered in Westminster, CO.

  • What is the size of CardioNXT?

    CardioNXT has 11 total employees.

  • What industry is CardioNXT in?

    CardioNXT’s primary industry is Biotechnology.

  • Is CardioNXT a private or public company?

    CardioNXT is a Private company.

  • What is CardioNXT’s current revenue?

    The current revenue for CardioNXT is .

  • How much funding has CardioNXT raised over time?

    CardioNXT has raised $7.6M.

  • Who are CardioNXT’s investors?

    , Piedmont Capital Partners, , Solas BioVentures, and Colorado Venture Capital Authority have invested in CardioNXT.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process